
A New Obesity Contender From China Targeting Same Receptors As Eli Lilly's Blockbuster
The Chinese drug company is looking to break into the big league for weight-loss treatments after its injection demonstrated sustained weight loss in Phase Three trials Key Takeaways: Participants receiving the highest dose in the 48-week Chinese trial …